425: Semler Scientific Director Posts on Strive Merger

Semler Scientific's Director of Bitcoin Strategy shared posts on X.com regarding the proposed acquisition by Strive, Inc., prompting SEC filings for stockholder approval.

Summary

• Semler Scientific's Director of Bitcoin Strategy, Joe Burnett, made several posts on his X.com account on December 31, 2025, concerning the proposed acquisition of Semler Scientific by Strive, Inc.
• Strive has filed a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued by Strive in connection with the proposed transaction.
• This Registration Statement includes an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive (collectively, the Information Statement/Proxy Statement/Prospectus).
• A definitive Information Statement/Proxy Statement/Prospectus was sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Strive, Semler Scientific, and certain of their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive as it confirms the ongoing procedural steps for a merger, which can be a strategic positive. However, it also includes extensive cautionary language about risks, preventing a higher score. No new positive or negative operational news is presented.

Risks

• Volatility in Bitcoin, along with other risks related to Semler Scientific's Bitcoin treasury strategy and its healthcare business.
• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction, including anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. However, no specific financial guidance or estimates are provided.

Management Comments

• Joe Burnett, Director of Bitcoin Strategy of Semler Scientific, made several posts on his X.com account concerning the proposed acquisition of Semler Scientific by Strive, Inc.

Industry Context

This filing provides a procedural update on a proposed merger, a common strategic move for companies seeking growth or consolidation. Semler Scientific's mention of a 'Bitcoin treasury strategy' highlights a growing trend among some companies to incorporate digital assets into their balance sheets, which can introduce new risk factors alongside potential benefits. The acquisition by Strive suggests a strategic expansion or diversification for the acquiring entity.

Stakeholder Impact

• Shareholders (Semler Scientific): Will vote on the proposed transaction and, if approved, will receive Strive Class A common stock, subject to potential dilution.
• Shareholders (Strive): Will experience dilution due to the issuance of new Class A common stock for the acquisition.
• Employees: Potential changes to business or employee relationships may arise from the announcement or completion of the proposed transaction.
• Customers: Potential adverse reactions or changes to relationships may arise from the announcement or completion of the proposed transaction.

Next Steps

• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus regarding the proposed transaction.
• Stockholders of Semler Scientific are to seek their approval of the proposed transaction.
• Strive and Semler Scientific may file with the SEC any other relevant documents concerning the proposed transaction.

Key Dates

Recommendation

This filing is a procedural update regarding the proposed acquisition of Semler Scientific by Strive, Inc., primarily detailing SEC filing requirements and proxy solicitation. It does not introduce new financial performance data, strategic initiatives, or material changes to the deal terms that would alter an existing investment thesis. While the merger itself is a significant event, this specific communication serves as a reminder of the ongoing process and associated risks. Therefore, a 'hold' recommendation is appropriate for investors to await the outcome of the stockholder vote and further details on the integration and combined entity's prospects before making a more definitive investment decision.

Keywords

Semler Scientific, Strive Inc, Merger, Acquisition, SEC Filing, Form 425, Bitcoin Strategy, Proxy Statement, Stockholder Approval, Corporate Governance